Varubi Tablet
Product Images NDC 70720-101

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Varubi (NDC 70720-101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Tersera Therapeutics Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Ter0b 0000 01

Ter0b 0000 01
FDA Label Image

Ter0b 0000 02

Ter0b 0000 02
Not available.*
FDA Label Image

Ter0b 0000 03

Ter0b 0000 03
FDA Label Image

Ter0b 0000 04

Ter0b 0000 04
FDA Label Image

Ter0b 0000 05

Ter0b 0000 05
FDA Label Image

Ter0b 0000 06

Ter0b 0000 06
VARUBI (rolapitant) is a prescription medicine available in tablet form. The package contains two 90 mg tablets, which is equivalent to a single dose of 180 mg. VARUBI is used in adults undergoing chemotherapy to prevent nausea and vomiting. This package is child-proof and should be kept out of children's reach. The drug should be stored at a temperature between 20 and 25°C, with short excursions permitted to 15°C - 30°C. For more information on correct dosage, refer to the package insert.*
FDA Label Image

Ter0b 0000 07

Ter0b 0000 07

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.